Stock News

Real-time ticker analysis, price-action alerts, and institutional-grade stock data.

PTHS
$20.00-20.00%
4/7, 4:59 AM

Pelthos Therapeutics (NYSEAMERICAN:PTHS) Director Peter Greenleaf Sells 797 Shares

Pelthos Therapeutics Inc. (NYSEAMERICAN:PTHS - Get Free Report) Director Peter Greenleaf sold 797 shares of the business's stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an average price of $20.92, for a total transaction of $16,673.24. Following the transaction, the director directly owned 24,681 shares of the company's

defenseworld.netView Stock
REZI
$36.00+3.27%
4/7, 4:59 AM

Resideo Technologies, Inc. (NYSE:REZI) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Resideo Technologies, Inc. (NYSE: REZI - Get Free Report) have been given an average rating of "Hold" by the five research firms that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and two have given a buy recommendation

defenseworld.netView Stock
PTHS
$20.00-20.00%
4/7, 4:59 AM

Pelthos Therapeutics (NYSEAMERICAN:PTHS) Director Ezra Friedberg Sells 558 Shares

Pelthos Therapeutics Inc. (NYSEAMERICAN:PTHS - Get Free Report) Director Ezra Friedberg sold 558 shares of Pelthos Therapeutics stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an average price of $20.92, for a total transaction of $11,673.36. Following the transaction, the director owned 82,027 shares of the company's stock,

defenseworld.netView Stock
STLA
$7.54+0.80%
4/7, 4:59 AM

Stellantis: Early Signs Of Turnaround With Product Momentum And Regulatory Relief

Improving product mix, solid momentum in key markets (US and Italy), and a strong H2 pipeline support a gradual recovery in volumes and margins. Greater flexibility on EU CO₂ targets and the Leapmotor agreement reduce compliance risk, while prior restructuring actions position the company for EBIT recovery in 2026. Trading at depressed multiples, we believe Stellantis offers significant upside, with earnings recovery and capital markets day acting as potential catalysts.

seekingalpha.comView Stock
KFFB
$4.70+8.29%
4/7, 4:57 AM

Kentucky First Federal Bancorp (NASDAQ:KFFB) Share Price Passes Below Fifty Day Moving Average – Here’s What Happened

Kentucky First Federal Bancorp (NASDAQ: KFFB - Get Free Report) shares crossed below its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $4.60 and traded as low as $4.33. Kentucky First Federal Bancorp shares last traded at $4.4950, with a volume of 5,977 shares trading hands. Wall Street

defenseworld.netView Stock
IOVA
$3.30+0.00%
4/7, 4:57 AM

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Cross Below 50 Day Moving Average – Here’s What Happened

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA - Get Free Report)'s share price passed below its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $3.42 and traded as low as $3.28. Iovance Biotherapeutics shares last traded at $3.30, with a volume of 9,777,900 shares traded. Wall Street Analyst Weigh In

defenseworld.netView Stock
UBS
$39.36-0.83%
4/7, 4:56 AM

UBS trims Whitbread price target as sluggish UK hotel market clouds near-term outlook

UBS has nudged down its price target on Whitbread PLC (LSE:WTB), the Premier Inn owner, from 3,605p to 3,575p and cut profit forecasts through to 2028, citing a lacklustre start to the year for UK hotel room rates and a growing list of economic headwinds facing the business. The Swiss bank said revenue per available room, a key industry performance metric known as RevPAR, had turned slightly negative since the start of 2026, weighed down by stalling interest rate cuts, inflationary pressure linked to the Middle East conflict and rising unemployment.

proactiveinvestors.co.ukView Stock
CTPVF
$18.90+15.77%
4/7, 4:54 AM

CTP N.V. Notice of Q1-2026 Results

AMSTERDAM--(BUSINESS WIRE)--Regulatory News: CTP N.V. (CTPNV.AS), (“CTP”, the “Group” or the “Company”), Europe's largest listed owner, developer and manager of logistics and industrial real estate by gross lettable area, will announce its Q1-2026 results on Thursday, 30 April 2026. On the day, at 09.00AM (GMT) / 10.00AM (CET) the Company will host a video presentation and Q&A session for analysts and investors, via a live webcast and audio conference call. The live webcast can be viewed th.

businesswire.comView Stock
CAG
$15.79+0.06%
4/7, 4:52 AM

Conagra: I Am Buying This Value (Rating Upgrade)

Conagra is deeply undervalued, trading at a forward P/E of 9.25 and offering a near 9% dividend yield. Dividend coverage remains achievable with projected FY26 earnings of $1.70, though input and energy cost risks persist. I target $18.70 per share (forward P/E 11) as fair value, with contrarian upside and attractive option strategies available.

seekingalpha.comView Stock
CAB
$63.10+0.00%
4/7, 4:51 AM

Form 8.5 (EPT/RI) - CAB Payments Holdings Plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd (b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree CAB Payments Holdings Plc (c)        Name of the party to the offer with which exempt principal trader is connected: CAB Payments Holdings Plc (d)        Date dealing undertaken: 02 April 2026 (e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

globenewswire.comView Stock
ERJ
$65.75+1.91%
4/7, 4:49 AM

Embraer: $50 Billion In Contracted And Optioned Backlogs Bodes Well For FY 2026

Embraer is rated Buy, supported by strong backlogs, conservative guidance, and attractive valuation versus peers. FY 2025 saw 18.5% revenue growth to $7.6B, with all segments showing healthy expansion and a record $31.6B backlog ($50B with options). Management's FY 2026 guidance appears conservative, setting up potential for revenue beats and margin expansion, especially in D&S.

seekingalpha.comView Stock
UNH
$300.85+6.93%
4/7, 4:33 AM

Should you buy UnitedHealth stock after UNH soars 9% in a day

Though it remains far below its historic highs, the stock of UnitedHealth (NYSE: UNH) achieved a notable climb during the April 6 session as it rose 1.48% from the previous closing price of $277.26 to its latest closing price of $281.36. Subsequently, the UNH shares rally was turbocharged as the equity rocketed 7.74% after-hours to $303.15.

finbold.comView Stock
FNLPF
$46.80+5.12%
4/7, 4:25 AM

Fresnillo and other precious metals miners lead FTSE fallers as gold wavers

Precious metals miners Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) and Fresnillo PLC (LSE:FRES) led the FTSE 100 fallers after the four-day Easter weekend. This reflected the London-listed shares catching up with the fall in gold and silver prices at the end of last week, with gold dropping from over $4,880 an ounce on Thursday to $4,651 today, while silver has fallen from $75.5 an ounce on Thursday to $72.6.

proactiveinvestors.co.ukView Stock
EXPE
$229.90+0.38%
4/7, 4:13 AM

Expedia: Margin Expansion Supports Re-Entry Opportunity

Expedia delivered a clean beat across revenue, EBITDA, and EPS, with 9% room night growth and meaningful margin expansion driven by operating leverage and marketing efficiency. Middle East exposure remains immaterial (~1–2% of sales), with travel demand holding up well, supported by strong US trends, improving EMEA B2C performance, and continued B2B momentum. Expedia maintains a strong cash position and raised its quarterly dividend by 20%.

seekingalpha.comView Stock
REAL-TIME FEEDTERMINAL PAGE 8